CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
Funding Amount
$2,500,000 total
Deadline
November 5, 2028
762 days left
Number of Awards
5
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Public colleges & universities
- County governments
- Public & Indian housing authorities
- Nonprofits (501(c)(3))
- School districts
- Private colleges & universities
- Small businesses
- State governments
Overview
Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) together with the National Institute of Allergy and Infectious Diseases (NIAID) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications aimed at elucidating the pathological mechanisms underlying skin injury caused by toxic chemicals identified by the U.S. Department of Homeland Security as high-consequence public health threats. This initiative will emphasize the understanding of commonalities in the fundamental mechanisms of skin injuries caused by vesicants such as sulfur mustard, Lewisite, nitrogen mustard, phosgene oxime, arsenicals, and other toxic chemicals. Responsive applications will investigate the molecular and cellular pathology of at least two chemicals, belonging to different toxidromes (contact PO for more information). It is hoped that the knowledge gained will ultimately lead to the discovery and characterization of potential shared therapeutic targets in injuries caused by different chemicals, and the development of broad-spectrum medical countermeasures (MCM). This effort is part of a NIH-wide initiative to develop MCM to treat patients in mass casualty events after acute exposure to toxic chemicals as part of the Chemical Countermeasure Research Program (CCRP). Chemical Countermeasures Research Program | NIAID: National Institute of Allergy and Infectious Diseases . Applications are not being solicited currently. Notice is provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R01 activity code. Investigators with expertise and insights into this cutaneous wound healing area are encouraged to consider applying for this new NOFO. In addition, team science approaches will be encouraged.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: FOR-AR-26-010
- Total Funding: $2,500,000
- Expected Awards: 5
- Instrument: grant
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed). Now let's win it.